Novartis weighs deal for biotech Avidity Biosciences, FT reports
Corrects typo in paragraph 1 Aug 6 (Reuters) - Swiss drugmaker Novartis NOVN.S has approached U.S. biotech Avidity Biosciences for a potential takeover offer, the Financial Times reported, citing people familiar with the matter (Reporting by Padmanabhan Ananthan in Bengaluru; Editing by Arun Koyyur) ((Padmanabhan.Ananthan@thomsonreuters.com;))
Recent news on Avidity Biosciences
See all newsFactbox: Pharma sector doubles down on AI amid hopes of slashing costs, timelines
Factbox: Pharma sector doubles down on AI amid hopes of slashing costs, timelines
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:28 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:28 AM
Brief: Avidity Biosciences Says Record Date Set For February 12, 2026 For Spin-Off